New patent for Mallinckrodt Hosp drug INOMAXBy DrugPatentWatch – Make Better Decisions / May 16, 2024 Annual Drug Patent Expirations for INOMAX Inomax is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from one supplier. There are fifteen patents…Source